esmolol has been researched along with Postoperative Complications in 62 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (12.90) | 18.7374 |
1990's | 19 (30.65) | 18.2507 |
2000's | 20 (32.26) | 29.6817 |
2010's | 14 (22.58) | 24.3611 |
2020's | 1 (1.61) | 2.80 |
Authors | Studies |
---|---|
Han, J; Liu, RC; Sun, DF; Sun, SH; Wang, LJ; Wu, Y; Yang, L | 1 |
Chen, QH; Hu, Q; Wang, WX; Zhang, XK | 1 |
Ollila, A; Pettilä, V; Sund, R; Vikatmaa, L; Wilkman, E | 1 |
Balakrishnan, A; Beer, KS; Hart, SK | 1 |
Freundlich, RE; Kheterpal, S; Mashour, GA; Matlen, L; Merte, J; Nallamothu, BK; Shanks, A; Sharifpour, M; Tremper, KK; Vlisides, PE; Weightman, A | 1 |
Cho, ML; Her, YM; Huh, JW; Kang, SH; Kim, YS; Lee, J; Song, KY | 1 |
Furck, A; Jivanji, SG; Slavik, Z | 1 |
Badri, AM; Bebawy, JF; Carabini, LM; Gupta, DK; Hemmer, LB; Houston, CC; Koht, A; Kosky, JL; Moreland, NC | 1 |
Makris, D; Papanikolaou, J; Spathoulas, K; Tsolaki, V; Zakynthinos, E | 1 |
Adamson, PC; Backer, CL; Bokesch, P; Hoffman, ML; McGowan, FX; Nicolson, SC; Schreiner, M; Tabbutt, S; Tweddell, JS; Wells, W; Zhang, X | 1 |
Marik, PE; Varon, J | 1 |
Bilotta, F; Cuzzone, V; Delfini, R; Doronzio, A; Lam, AM; Rosa, G | 1 |
Boldt, J; Lang, K; Mayer, J; Mengistu, A; Suttner, S | 1 |
Belloni, I; Bignami, E; Biondi-Zoccai, G; Cornero, G; Landoni, G; Testa, V; Turi, S; Zangrillo, A | 1 |
Beattie, WS; Karkouti, K; McCluskey, S; Tait, G; Wijeysundera, D; Yu, SK | 1 |
Ding, Z; Qian, Y; Sun, J | 1 |
Gui, P; Wu, J; Wu, Q; Yao, S | 1 |
Geissler, HJ; Kuhn-Régnier, F; Mehlhorn, U | 1 |
Hilleman, DE; Mooss, AN; Packard, KA; Reyes, AP | 1 |
Berry, C; Corbett, W; Fleisher, LA; Poldermans, D | 1 |
Boussofara, M; Bracco, D; Chrayti, H; Ravussin, P | 1 |
Boldt, J; Brosch, C; Isgro, F; Lehmann, A; Suttner, S | 1 |
Abe, F; Imamura, M; Masamune, T; Nonaka, A; Suzuki, S | 2 |
Gray, RJ | 1 |
Kaplan, JA | 1 |
Mathews, L; Pandharipande, P; Thompson, R; Turner, S | 1 |
Covello, RD; Crescenzi, G; Landoni, G; Marino, G; Rosica, C; Serini, SM; Zangrillo, A | 1 |
Dimich, I; Herschman, Z; Singh, PP | 1 |
Chu, SH; Ko, WJ | 1 |
Casimir-Ahn, H; Granfeldt, H; Lönn, U; Peterzén, B | 1 |
Karski, JM; Redahan, C | 1 |
O'Shea, PJ; Ooi, LG; Wood, AJ | 1 |
Harris, MN; O'Dwyer, JP; Yorukoglu, D | 1 |
Crosse, MM; Knighton, JD | 1 |
Garner, SS; Sade, RM; Uber, WE; Wiest, DB | 1 |
Borowski, A; Korb, H | 1 |
Borowski, A; Eichstaedt, HC; Korb, H; Raji, MR; Schickendantz, S | 1 |
Balser, JR; Breslow, MJ; Campbell, K; Clarke, AW; Dorman, T; Huang, W; Lipsett, P; Martinez, EA; Perdue, PW; Rosenfeld, BA; Tomaselli, GF; Winters, BD | 1 |
Akhtar, S; Brull, SJ; Naimi, C; Raby, KE; Rosenbaum, S; Timimi, F; Whittemore, AD | 1 |
Dapunt, O; Dhein, S; Geissler, HJ; Görg, C; Kuhn-Régnier, F; LaRosé, K; Mehlhorn, U; Natour, E | 1 |
Butterworth, J; Dean, R; Hansen, K; Harwood, TN; Plonk, G; Prielipp, RC; Royster, RL | 1 |
Atlee, JL; Dhamee, MS; George, V; Olund, TL | 1 |
Allen, SJ; Davis, KL; Geissler, HJ; Hekmat, K; Laine, GA; Mehlhorn, U; Ostrin, EJ; Warters, RD | 1 |
Hilleman, DE; Mohiuddin, SM; Mooss, AN; Reyes, AP; Scott, W; Seyedroudbari, A; Sugimoto, JT; Wurdeman, RL | 1 |
Harmoinen, A; Kaukinen, S; Rinne, T | 1 |
Evans, R; Fernandes, NO; Kurian, SM; Sherry, KM | 1 |
Van Besouw, J | 1 |
Balcetyte-Harris, N; Homel, P; Menchavez, E; Steinberg, JS; Tamis, JE | 1 |
Hill, GA; Owens, SD | 1 |
Black, S; Cucchiara, RF; Losasso, TJ; Muzzi, DA | 1 |
Click, LA; Plauth, WH; Vincent, RN; Williams, HM; Williams, WH | 1 |
Boylan, JF; Ivanov, J; Mickle, DA; O'Leary, G; Teasdale, SJ; Weisel, RD | 1 |
Gersony, WM; Smerling, A | 1 |
Arthaud, M; Coriat, P; Daas, G; Kalfon, F; Lasnier, H; Le Bret, F; Viars, P | 1 |
Bateman, TM; Conklin, CM; Czer, LS; Gray, RJ; Matloff, JM | 1 |
Bateman, TM; Conklin, C; Czer, LS; Gray, RJ; Matloff, JM | 2 |
Angaran, DM; Schultz, NJ; Tschida, VH | 1 |
MacVaugh, H; Michelson, EL; Sawin, HS; Schwartz, M | 1 |
9 review(s) available for esmolol and Postoperative Complications
Article | Year |
---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
Efficacy and safety of intravenous esmolol for cardiac protection in non-cardiac surgery. A systematic review and meta-analysis.
Topics: Acute Kidney Injury; Administration, Intravenous; Adrenergic beta-1 Receptor Antagonists; Bradycardia; Female; Heart; Heart Diseases; Hemodynamics; Humans; Hypotension; Male; Myocardial Infarction; Myocardial Ischemia; Perioperative Care; Postoperative Complications; Propanolamines; Protective Agents; Randomized Controlled Trials as Topic; Safety | 2019 |
Perioperative hypertension management.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Enalaprilat; Fenoldopam; Hemodynamics; Humans; Hydralazine; Hypertension; Incidence; Labetalol; Nicardipine; Nitroglycerin; Nitroprusside; Perioperative Care; Postoperative Complications; Propanolamines; Pyridines; Surgical Procedures, Operative; Vascular Resistance; Vasodilator Agents | 2008 |
Esmolol reduces perioperative ischemia in noncardiac surgery: a meta-analysis of randomized controlled studies.
Topics: Adrenergic beta-Antagonists; Humans; Myocardial Ischemia; Perioperative Care; Postoperative Complications; Propanolamines; Randomized Controlled Trials as Topic | 2010 |
The safety of perioperative esmolol: a systematic review and meta-analysis of randomized controlled trials.
Topics: Adrenergic beta-1 Receptor Antagonists; Blood Pressure; Bradycardia; Dose-Response Relationship, Drug; Drug Administration Schedule; Evidence-Based Medicine; Heart Rate; Humans; Hypotension; Myocardial Ischemia; Perioperative Care; Postoperative Complications; Propanolamines; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Treatment Outcome | 2011 |
Postcardiac surgical hypertension.
Topics: Cardiac Surgical Procedures; Heart Rate; Humans; Hypertension; Labetalol; Nitroprusside; Norepinephrine; Postoperative Complications; Propanolamines; Vascular Resistance | 1988 |
Dupont critical care lecture: role of ultrashort-acting beta-blockers in the perioperative period.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Coronary Artery Bypass; Heart Rate; Humans; Hypertension; Intraoperative Complications; Myocardial Ischemia; Postoperative Complications; Propanolamines; Tachycardia, Supraventricular | 1988 |
[The use of short-acting beta-blockers in cardiac surgery].
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Aorta, Thoracic; Arrhythmias, Cardiac; Cardiac Surgical Procedures; Cardioplegic Solutions; Catecholamines; Drug Therapy, Combination; Extracorporeal Circulation; Half-Life; Heart; Hemodynamics; Humans; Hypertension; Intraoperative Complications; Myocardium; Postoperative Complications; Propanolamines; Stress, Physiological; Vasodilator Agents | 2001 |
Esmolol hydrochloride: an ultrashort-acting, beta-adrenergic blocking agent.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Chemical Phenomena; Chemistry; Coronary Disease; Drug Interactions; Female; Heart; Hemodynamics; Humans; Hypertension; Kinetics; Lactation; Myocardial Infarction; Postoperative Complications; Pregnancy; Pregnancy Complications, Cardiovascular; Propanolamines; Tachycardia | 1986 |
27 trial(s) available for esmolol and Postoperative Complications
Article | Year |
---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
Effects of vasodilator and esmolol-induced hemodynamic stability on early post-operative cognitive dysfunction in elderly patients: a randomized trial.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Catheter Ablation; Cognitive Dysfunction; Female; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Male; Mental Status and Dementia Tests; Nicardipine; Nitroglycerin; Postoperative Complications; Propanolamines; Vasodilator Agents | 2016 |
The effect of continuous perfusion of esmolol on cardiovascular risk in elderly patients undergoing noncardiac surgery.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Aged, 80 and over; Cardiovascular Diseases; Female; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Intubation, Intratracheal; Laparoscopy; Male; Middle Aged; Oxygen Consumption; Postoperative Complications; Propanolamines; Risk Factors; Time Factors | 2017 |
Nicardipine is superior to esmolol for the management of postcraniotomy emergence hypertension: a randomized open-label study.
Topics: Aged; Anesthesia Recovery Period; Antihypertensive Agents; Brain Neoplasms; Craniotomy; Female; Humans; Hypertension; Male; Middle Aged; Nicardipine; Postoperative Complications; Propanolamines | 2015 |
The safety, efficacy, and pharmacokinetics of esmolol for blood pressure control immediately after repair of coarctation of the aorta in infants and children: a multicenter, double-blind, randomized trial.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Aortic Coarctation; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypertension; Infant; Infant, Newborn; Male; Postoperative Complications; Propanolamines | 2008 |
Influence of continuous perioperative beta-blockade in combination with phosphodiesterase inhibition on haemodynamics and myocardial ischaemia in high-risk vascular surgery patients.
Topics: Adrenergic beta-Antagonists; Aged; Aorta, Abdominal; Cardiac Output; Cardiotonic Agents; Drug Administration Schedule; Drug Therapy, Combination; Enoximone; Female; Humans; Intraoperative Complications; Male; Middle Aged; Myocardial Ischemia; Perioperative Care; Phosphodiesterase 3 Inhibitors; Phosphodiesterase Inhibitors; Postoperative Complications; Propanolamines; Prospective Studies; Single-Blind Method | 2009 |
Effect of short-acting beta blocker on the cardiac recovery after cardiopulmonary bypass.
Topics: Adrenergic beta-Antagonists; Analysis of Variance; Cardiopulmonary Bypass; Chi-Square Distribution; Female; Heart Valve Prosthesis Implantation; Humans; Male; Mitral Valve; Postoperative Complications; Propanolamines; Prospective Studies; Recovery of Function; Rheumatic Heart Disease | 2011 |
Protective effect of esmolol on myocardial ischemic injury during open heart surgery in children.
Topics: Adrenergic beta-Antagonists; Arterial Pressure; Cardiac Surgical Procedures; Cardiotonic Agents; Child, Preschool; Creatine Kinase; Dopamine; Double-Blind Method; Female; Heart Rate; Humans; Infant; Intraoperative Complications; Male; Myocardial Ischemia; Postoperative Complications; Preanesthetic Medication; Propanolamines; Treatment Outcome; Troponin I | 2013 |
[Comparison of three protocols in the control of cardiovascular response to suspended laryngoscopy in ENT surgery].
Topics: Adrenergic beta-Antagonists; Adult; Anti-Arrhythmia Agents; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Female; Heart Rate; Humans; Laryngoscopy; Lidocaine; Male; Middle Aged; Nicardipine; Postoperative Complications; Propanolamines; Risk Factors | 2004 |
The prophylactic use of the beta-blocker esmolol in combination with phosphodiesterase III inhibitor enoximone in elderly cardiac surgery patients.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-Antagonists; Aged; Biomarkers; Blood Gas Analysis; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cyclic Nucleotide Phosphodiesterases, Type 3; Endothelium, Vascular; Enoximone; Female; Glutathione Transferase; Heart Rate; Hemodynamics; Humans; Inflammation; Kidney Function Tests; Male; Monitoring, Intraoperative; Myocardial Ischemia; Phosphodiesterase Inhibitors; Postoperative Complications; Propanolamines; Splanchnic Circulation | 2004 |
A new dosing regimen for esmolol to treat supraventricular tachyarrhythmia in Chinese patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Cardiac Surgical Procedures; Dose-Response Relationship, Drug; Female; Humans; Hypotension; Infusions, Intravenous; Male; Middle Aged; Postoperative Complications; Propanolamines; Tachycardia, Supraventricular; Taiwan; Time Factors | 1994 |
Coronary artery operation with support of the Hemopump cardiac assist system.
Topics: Adrenergic beta-Antagonists; Aged; Blood Loss, Surgical; Coronary Artery Bypass; Female; Heart-Assist Devices; Hemodynamics; Humans; Male; Middle Aged; Postoperative Complications; Propanolamines | 1994 |
The use of esmolol to attenuate the haemodynamic response when extubating patients following cardiac surgery--a double-blind controlled study.
Topics: Adrenergic beta-Antagonists; Anesthesia Recovery Period; Coronary Artery Bypass; Double-Blind Method; Female; Hemodynamics; Humans; Intubation, Intratracheal; Male; Middle Aged; Postoperative Complications; Propanolamines; Ventilator Weaning | 1993 |
Esmolol for the management of pediatric hypertension after cardiac operations.
Topics: Adrenergic beta-Antagonists; Aortic Coarctation; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Heart Defects, Congenital; Humans; Hypertension; Infant; Male; Postoperative Complications; Propanolamines | 1998 |
Beta-adrenergic blockade accelerates conversion of postoperative supraventricular tachyarrhythmias.
Topics: Adrenergic beta-Antagonists; Aged; Calcium Channel Blockers; Critical Care; Diltiazem; Double-Blind Method; Electrocardiography; Female; Heart Rate; Humans; Injections, Intravenous; Male; Postoperative Complications; Propanolamines; Tachycardia, Supraventricular; Time Factors | 1998 |
The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery.
Topics: Adrenergic beta-Antagonists; Aged; Aortic Aneurysm; Electrocardiography, Ambulatory; Endarterectomy, Carotid; Female; Heart Rate; Humans; Male; Myocardial Ischemia; Placebos; Postoperative Complications; Propanolamines; Risk Factors | 1999 |
Beta-blockade versus Buckberg blood-cardioplegia in coronary bypass operation.
Topics: Adrenergic beta-Antagonists; Aged; Cardiopulmonary Bypass; Coronary Artery Bypass; Female; Follow-Up Studies; Heart Arrest, Induced; Heart Ventricles; HSP70 Heat-Shock Proteins; Humans; Hypothermia, Induced; Infusions, Intravenous; Intercellular Adhesion Molecule-1; Intraoperative Period; Male; Middle Aged; Myocardial Ischemia; Postoperative Complications; Propanolamines; Prospective Studies; Treatment Outcome; Ventricular Function, Left | 1999 |
The safety and effectiveness of esmolol in the perioperative period in patients undergoing abdominal aortic surgery.
Topics: Adrenergic beta-Antagonists; Aged; Aorta, Abdominal; Electrocardiography; Female; Heart Rate; Humans; Intraoperative Complications; Intraoperative Period; Male; Middle Aged; Monitoring, Intraoperative; Myocardial Ischemia; Postoperative Complications; Propanolamines; Prospective Studies | 1999 |
The use of esmolol, nicardipine, or their combination to blunt hemodynamic changes after laryngoscopy and tracheal intubation.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Anesthesia, Inhalation; Arrhythmias, Cardiac; Blood Pressure; Calcium Channel Blockers; Drug Therapy, Combination; Female; Heart Rate; Hemodynamics; Humans; Intubation, Intratracheal; Laryngoscopy; Male; Middle Aged; Nicardipine; Postoperative Complications; Propanolamines | 2000 |
Esmolol versus diltiazem in the treatment of postoperative atrial fibrillation/atrial flutter after open heart surgery.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atrial Fibrillation; Atrial Flutter; Coronary Artery Bypass; Cost-Benefit Analysis; Diltiazem; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Postoperative Complications; Probability; Prognosis; Propanolamines; Reference Values; Survival Rate; Treatment Outcome | 2000 |
Esmolol cardioplegia in unstable coronary revascularisation patients. A randomised clinical trial.
Topics: Adrenergic beta-Antagonists; Aged; Cardioplegic Solutions; Coronary Artery Bypass; Creatine Kinase; Double-Blind Method; Electrocardiography; Female; Humans; Lactic Acid; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Myoglobin; Postoperative Complications; Propanolamines; Prospective Studies; Troponin | 2000 |
The effect of an infusion of esmolol on the incidence of myocardial ischaemia during tracheal extubation following coronary artery surgery.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Cardiopulmonary Bypass; Coronary Disease; Device Removal; Female; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Intubation, Intratracheal; Male; Middle Aged; Myocardial Ischemia; Postoperative Care; Postoperative Complications; Propanolamines | 2001 |
Randomized study of early intravenous esmolol versus oral beta-blockers in preventing post-CABG atrial fibrillation in high risk patients identified by signal-averaged ECG: results of a pilot study.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Bradycardia; Coronary Artery Bypass; Drug Administration Schedule; Electrocardiography; Female; Humans; Hypotension; Infusions, Intravenous; Male; Middle Aged; Pilot Projects; Postoperative Complications; Propanolamines | 2002 |
A comparison of diltiazem, esmolol, nifedipine and nitroprusside therapy of post-CABG hypertension.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Coronary Artery Bypass; Coronary Circulation; Diltiazem; Energy Metabolism; Ferricyanides; Humans; Hypertension; Infusions, Intravenous; Myocardium; Nifedipine; Nitroprusside; Postoperative Complications; Propanolamines; Prospective Studies; Randomized Controlled Trials as Topic | 1990 |
Use of esmolol in hypertension after cardiac surgery.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Drug Administration Schedule; Female; Heart Diseases; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Nitroprusside; Postoperative Complications; Propanolamines; Random Allocation | 1985 |
Comparison of esmolol and nitroprusside for acute post-cardiac surgical hypertension.
Topics: Adrenergic beta-Antagonists; Aged; Cardiac Surgical Procedures; Catecholamines; Dose-Response Relationship, Drug; Female; Ferricyanides; Hemodynamics; Humans; Hypertension; Infusions, Intravenous; Male; Middle Aged; Nitroprusside; Oxygen; Postoperative Complications; Propanolamines; Random Allocation | 1987 |
Esmolol: safety and efficacy in postoperative cardiothoracic patients with supraventricular tachyarrhythmias.
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Atrial Flutter; Blood Pressure; Clinical Trials as Topic; Coronary Artery Bypass; Female; Heart Rate; Heart Valve Prosthesis; Humans; Male; Postoperative Complications; Propanolamines; Time Factors | 1988 |
27 other study(ies) available for esmolol and Postoperative Complications
Article | Year |
---|---|
Successful management of persistent tachycardia using esmolol in 2 dogs with septic shock.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Digestive System Surgical Procedures; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Norepinephrine; Postoperative Complications; Propanolamines; Shock, Septic; Tachycardia, Supraventricular; Vasoconstrictor Agents | 2019 |
Perioperative metoprolol and risk of stroke after noncardiac surgery.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Analysis of Variance; Atenolol; Cohort Studies; Data Interpretation, Statistical; Female; Humans; Incidence; Labetalol; Logistic Models; Male; Metoprolol; Middle Aged; Monitoring, Intraoperative; Odds Ratio; Postoperative Complications; Propanolamines; Retrospective Studies; Risk Factors; Stroke; Treatment Outcome; Young Adult | 2013 |
The immunomodulatory role of esmolol in patients undergoing laparoscopic gastrectomy due to gastric cancer.
Topics: Adrenergic beta-1 Receptor Antagonists; C-Reactive Protein; Enzyme-Linked Immunosorbent Assay; Female; Gastrectomy; Humans; Immunomodulation; Inflammation; Interferon-gamma; Interleukin-4; Interleukin-6; Intraoperative Period; Laparoscopy; Male; Middle Aged; Postoperative Complications; Postoperative Period; Propanolamines; Sodium Chloride; Stomach Neoplasms | 2013 |
β-blockers in postoperative myocardial diastolic dysfunction: not a panacea.
Topics: Adrenergic beta-Antagonists; Diastole; Heart Defects, Congenital; Humans; Infant, Newborn; Male; Postoperative Complications; Propanolamines; Ventricular Dysfunction, Left | 2014 |
Post-partum hemorrhage complicated by reverse-Takotsubo cardiogenic shock; a novel therapeutic approach.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Cesarean Section; Echocardiography; Female; Humans; Postoperative Complications; Postpartum Hemorrhage; Postpartum Period; Pregnancy; Prognosis; Propanolamines; Shock, Cardiogenic; Takotsubo Cardiomyopathy; Ventricular Function, Left | 2017 |
Esmolol blunts postoperative hemodynamic changes after propofol-remifentanil total intravenous fast-track neuroanesthesia for intracranial surgery.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Anesthesia Recovery Period; Anesthesia, Intravenous; Anesthetics, Intravenous; Blood Pressure; Craniotomy; Elective Surgical Procedures; Female; Heart Rate; Humans; Male; Middle Aged; Pain Measurement; Piperidines; Postoperative Complications; Propanolamines; Propofol; Prospective Studies; Remifentanil; Young Adult | 2008 |
Nurse joins in 'cover-up' of cause of death. Case on point: Thomas v. Hosp. Bd. of Dirs. of Lee County, 2D08-1671 FLCA2 (5/7/2010)-FL.
Topics: Adrenergic beta-Antagonists; Autopsy; Connecticut; Fatal Outcome; Female; Florida; Heart Arrest; Humans; Malpractice; Operating Room Nursing; Postoperative Complications; Propanolamines | 2010 |
The heavily calcified aorta and re-do CABG surgery: technical considerations how to avoid aortic crossclamp. How-to-do-it.
Topics: Adrenergic beta-Antagonists; Aged; Aortic Diseases; Calcinosis; Cardiotonic Agents; Constriction; Coronary Artery Bypass; Humans; Intraoperative Care; Middle Aged; Postoperative Complications; Propanolamines; Reoperation | 2002 |
Esmolol versus diltiazem in atrial fibrillation following coronary artery bypass graft surgery.
Topics: Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Calcium Channel Blockers; Coronary Artery Bypass; Diltiazem; Female; Humans; Male; Medical Records; Postoperative Complications; Propanolamines; Retrospective Studies; Treatment Outcome | 2003 |
Cost-effectiveness of differing perioperative beta-blockade strategies in vascular surgery patients.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aortic Aneurysm, Abdominal; Atenolol; Bisoprolol; Cost-Benefit Analysis; Decision Support Techniques; Humans; Infusions, Intravenous; Metoprolol; Perioperative Care; Postoperative Complications; Propanolamines; Treatment Outcome; Vascular Surgical Procedures | 2004 |
[Successful control of rapid heart rate with atrial flutter by intravenous administration of esmolol in a patient after total correction of the tetralogy of Fallot].
Topics: Adrenergic beta-Antagonists; Adult; Anesthesia, General; Atrial Flutter; Dilatation and Curettage; Female; Humans; Postoperative Care; Postoperative Complications; Pregnancy; Pregnancy Complications, Cardiovascular; Propanolamines; Tachycardia, Supraventricular; Tetralogy of Fallot; Treatment Outcome | 2004 |
[Intermittent complete left bundle branch block during general anesthesia].
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Anesthesia, General; Bundle-Branch Block; Diagnosis, Differential; Electrocardiography; Female; Humans; Lung Neoplasms; Perioperative Care; Pneumonectomy; Postoperative Complications; Propanolamines | 2004 |
Dolasetron-induced torsades de pointes.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Antiemetics; Cardiopulmonary Resuscitation; Electrocardiography; Female; Follow-Up Studies; Graves Disease; Humans; Hypertension; Hypotension; Indoles; Intraoperative Complications; Intubation, Intratracheal; Meningeal Neoplasms; Meningioma; Middle Aged; Postoperative Complications; Propanolamines; Quinolizines; Risk Factors; Torsades de Pointes; Vasoconstrictor Agents; Vasopressins | 2007 |
The use of esmolol to treat systolic anterior motion of the mitral valve after mitral valve repair.
Topics: Adrenergic beta-Antagonists; Humans; Mitral Valve; Mitral Valve Insufficiency; Postoperative Complications; Propanolamines; Ventricular Outflow Obstruction | 2008 |
Sudden death in a young postoperative patient given esmolol.
Topics: Abdominal Injuries; Adrenergic beta-Antagonists; Adult; Death, Sudden; Fatal Outcome; Humans; Male; Postoperative Complications; Propanolamines; Respiratory Distress Syndrome; Tachycardia, Supraventricular; Wounds, Gunshot | 1993 |
Thyrotoxicosis factitia in a post-aortocoronary bypass patient.
Topics: Adrenergic beta-Antagonists; Amrinone; Angina, Unstable; Coronary Artery Bypass; Humans; Isoquinolines; Male; Middle Aged; Myocardial Infarction; Neuromuscular Nondepolarizing Agents; Norepinephrine; Postoperative Complications; Propanolamines; Propofol; Thyroid Crisis; Thyroid Hormones; Thyrotoxicosis | 1994 |
Use of esmolol in the postbypass management of hypertrophic obstructive cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Cardiomyopathy, Hypertrophic; Female; Humans; Middle Aged; Postoperative Care; Postoperative Complications; Propanolamines; Ventricular Outflow Obstruction | 1993 |
Anaesthetic management of childhood thyrotoxicosis and the use of esmolol.
Topics: Adrenergic beta-Antagonists; Anesthesia, General; Female; Humans; Infant; Postoperative Complications; Propanolamines; Thyroid Crisis; Thyroidectomy; Thyrotoxicosis | 1997 |
Improved myocardial protection using continuous coronary perfusion with normothermic blood and beta-blockade with esmolol. A word of caution.
Topics: Adrenergic beta-Antagonists; Blood; Coronary Artery Bypass; Heart Defects, Congenital; Heart Valve Prosthesis Implantation; Humans; Mitral Valve; Myocardial Infarction; Myocardial Reperfusion; Postoperative Complications; Propanolamines; Treatment Outcome | 1998 |
Myocardial protection by pressure- and volume-controlled continuous hypothermic coronary perfusion in combination with Esmolol and nitroglycerine for correction of congenital heart defects in pediatric risk patients.
Topics: Adolescent; Adrenergic beta-Antagonists; Cardiopulmonary Bypass; Child; Child, Preschool; Coronary Vessels; Drug Therapy, Combination; Follow-Up Studies; Heart Defects, Congenital; Humans; Hypothermia, Induced; Infant; Infant, Newborn; Infusions, Intra-Arterial; Myocardial Reperfusion; Nitroglycerin; Postoperative Complications; Propanolamines; Retrospective Studies; Risk Factors; Treatment Outcome; Vasodilator Agents | 1998 |
Myocardial protection with high-dose beta-blockade in acute myocardial ischemia.
Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Biopsy; Cardiac Output, Low; Cardiopulmonary Bypass; Coronary Artery Bypass; Coronary Circulation; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Edema; Female; Heart Arrest, Induced; Male; Myocardial Ischemia; Myocardium; Postoperative Complications; Propanolamines; Ventricular Function, Left | 2000 |
Esmolol in the treatment of multifocal atrial tachycardia.
Topics: Adrenergic beta-Antagonists; Aged; Electrocardiography; Humans; Male; Postoperative Complications; Propanolamines; Tachycardia, Supraventricular | 1992 |
Labetalol and esmolol in the control of hypertension after intracranial surgery.
Topics: Adrenergic beta-Antagonists; Anesthesia, General; Brain; Heart Rate; Humans; Hypertension; Labetalol; Postoperative Complications; Propanolamines | 1990 |
Esmolol as an adjunct in the treatment of systemic hypertension after operative repair of coarctation of the aorta.
Topics: Adolescent; Adrenergic beta-Antagonists; Aortic Coarctation; Child; Drug Administration Schedule; Humans; Hypertension; Postoperative Complications; Propanolamines | 1990 |
Esmolol for severe hypertension following repair of aortic coarctation.
Topics: Adolescent; Adrenergic beta-Antagonists; Aortic Coarctation; Child, Preschool; Female; Humans; Hypertension; Infant; Male; Postoperative Complications; Propanolamines | 1990 |
[Repercussions of esmolol given in the treatment of postoperative tachycardia on left ventricular function].
Topics: Adrenergic beta-Antagonists; Heart; Heart Ventricles; Humans; Postoperative Complications; Propanolamines; Tachycardia | 1989 |
Esmolol: a new ultrashort-acting beta-adrenergic blocking agent for rapid control of heart rate in postoperative supraventricular tachyarrhythmias.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Blood Pressure; Cardiac Surgical Procedures; Digoxin; Dose-Response Relationship, Drug; Heart Rate; Humans; Hypotension; Infusions, Parenteral; Middle Aged; Postoperative Complications; Premedication; Propanolamines; Tachycardia | 1985 |